EQT Explores $600 Million Stake Sale in Singapore Healthcare Provider

Key Facts

In a move reflecting private equity strategies to monetize assets in emerging markets, Swedish firm EQT is exploring the sale of its stake in a Singapore-based healthcare provider. According to reports, the firm is seeking a valuation of approximately $600 million for the interest. This divestment aims to realize returns on its healthcare investments within the Southeast Asian market.

This potential sale comes amid heightened M&A activity in the Asian healthcare sector as investors capitalize on growing regional demand. At a $600 million valuation, the deal underscores EQT's active management of its alternative asset portfolio, following a period of sustained growth in its assets under management as noted in recent annual filings. Such exits are increasingly common as global private equity firms look to return capital to limited partners from their Asian holdings.

EQT shares (0IDU.L) stood at $51.50 at the close of June 11, 2026, having traded between a low of $51.13 and a high of $55.47 per market data. Investors are now watching for official confirmation of the buyer and the final deal terms. Additionally, market participants are looking ahead to Bank of England Governor Bailey's speech scheduled for later today, which may influence broader European market sentiment.